H pylori infection and systemic antibodies to CagA and heat shock protein 60 in patients with coronary heart disease.

scientific article

H pylori infection and systemic antibodies to CagA and heat shock protein 60 in patients with coronary heart disease. is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.3748/WJG.V12.I48.7815
P932PMC publication ID4087548
P698PubMed publication ID17203526
P5875ResearchGate publication ID298736281

P50authorNicola GiordanoQ42773464
Alberto PalazzuoliQ56574372
P2093author name stringAnnalisa Santucci
Natale Figura
Ranuccio Nuti
Michele Sozzi
Panagiotis Papakostas
Cristina Lenzi
Fabio Rollo
Catia Gonnelli
Giuliano Alegente
Maria-Stella Campagna
P2860cites workHelicobacter pylori and gastric cancerQ70600355
Relationship of immune response to heat-shock protein A and characteristics of Helicobacter pylori-infected patientsQ71735381
Antibody response to Helicobacter pylori CagA and heat-shock proteins in determining the risk of gastric cancer developmentQ73074082
Prospective study of potentially virulent strains of Helicobacter pylori and coronary heart disease in middle-aged menQ73660469
Comparative study on antibodies to human and bacterial 60 kDa heat shock proteins in a large cohort of patients with coronary heart disease and healthy subjectsQ73741235
Effect of H. pylori infection and CagA status on leukocyte counts and liver function tests: extra-gastric manifestations of H. pylori infectionQ77222223
The expression of heat shock protein 60 in patients with dilated cardiomyopathyQ77747713
Serum tumour necrosis factor-alpha is increased in patients with Helicobacter pylori infection and CagA antibodiesQ78057493
The heat-shock proteinsQ29617227
Infection and atherosclerosis: emerging mechanistic paradigmsQ33696699
Molecular mimicry in atherosclerosis: a role for heat shock proteins in immunisationQ35159020
Significant association of cagA positive Helicobacter pylori strains with risk of premature myocardial infarctionQ35567077
Heat shock proteins and stress in atherosclerosisQ35862376
The groES and groEL heat shock gene products of Escherichia coli are essential for bacterial growth at all temperaturesQ36174913
Helicobacter pylori infection in childhood: risk factors and effect on growthQ36888795
cag, a pathogenicity island of Helicobacter pylori, encodes type I-specific and disease-associated virulence factorsQ37047617
Stress proteins, autoimmunity, and autoimmune diseaseQ37765342
Prevalence of Helicobacter pylori infection in coronary artery disease and effect of its eradication on coronary lumen reduction after percutaneous coronary angioplastyQ37874031
Helicobacter pylori hspA-hspB heat-shock gene cluster: nucleotide sequence, expression, putative function and immunogenicity.Q38302075
Campylobacter pylori and peptic ulcer diseaseQ38596277
Analysis of expression of CagA and VacA virulence factors in 43 strains of Helicobacter pylori reveals that clinical isolates can be divided into two major types and that CagA is not necessary for expression of the vacuolating cytotoxinQ39820932
The role of heat shock proteins in protection and pathophysiology of the arterial wallQ41181626
Relation of Helicobacter pylori infection and coronary heart diseaseQ41333642
The multiple mechanisms by which infection may contribute to atherosclerosis development and courseQ43851339
Infection by CagA-positive Helicobacter pylori strains in patients with ischemic heart disease: prevalence and association with exercise-induced electrocardiographic abnormalitiesQ43980775
Helicobacter pylori-associated gastritis and primary B-cell gastric lymphomaQ44824307
Association of virulent Helicobacter pylori strains with ischemic heart disease.Q50887983
Helicobacter pylori infection is related to atheroma in patients undergoing coronary angiography.Q52867890
P433issue48
P407language of work or nameEnglishQ1860
P921main subjectHelicobacter pyloriQ180556
P304page(s)7815-7820
P577publication date2006-12-01
P1433published inWorld Journal of GastroenterologyQ15708885
P1476titleH pylori infection and systemic antibodies to CagA and heat shock protein 60 in patients with coronary heart disease
P478volume12

Reverse relations

cites work (P2860)
Q37772429Advantages of Moxifloxacin and Levofloxacin-based triple therapy for second-line treatments of persistent Helicobacter pylori infection: a meta analysis
Q24201388Antibiotics for secondary prevention of coronary heart disease
Q57389403Antibiotics for secondary prevention of coronary heart disease
Q39312633Application of proteomics to the study of Helicobacter pylori and implications for the clinic
Q36596797Association between Bacterial Infection and Peripheral Vascular Disease: A Review
Q33412165Clinical effects of Helicobacter pylori outside the stomach
Q38211000Clinical significance of Helicobacter pylori infection in patients with acute coronary syndromes: an overview of current evidence.
Q33376411Extragastric manifestations of Helicobacter pylori infection -- other Helicobacters
Q33401864Extragastrointestinal manifestations of Helicobacter pylori infection: facts or myth? A critical review
Q51475016Hsp60 and heme oxygenase-1 (Hsp32) in acute myocardial infarction.
Q92142495Identification of a novel anti‑heat shock cognate 71 kDa protein antibody in patients with Kawasaki disease
Q83217794Serum levels of high-sensitivity C-reactive protein (hs-CRP)in Helicobacter pylori-infected peptic ulcer patients and its association with bacterial CagA virulence factor

Search more.